Edition:
United Kingdom

People: Immunovia AB (publ) (IMMNOV.ST)

IMMNOV.ST on Stockholm Stock Exchange

149.80SEK
18 Sep 2019
Change (% chg)

0.20kr (+0.13%)
Prev Close
149.60kr
Open
148.00kr
Day's High
150.20kr
Day's Low
148.00kr
Volume
5,239
Avg. Vol
18,692
52-wk High
188.80kr
52-wk Low
128.00kr

Liljenborg, Hans 

Mr. Hans Liljenborg has served as Chief Financial Officer at Immunovia AB (publ) since 2013. Hans Liljenborg has a degree as subject teacher in Business Administration and Mathematics from Lund University, Sweden. Hans has long experience as Financial Manager for growing, global medical technology companies and has been Finance Director at Physio Control Inc, Jolife AB and Finance Manager at Vivoline Medical AB, listed on Nasdaq First North in March 2015. He also operates an own accounting firm. Hans Liljenborg is board member of ADAYS AB and deputy board member in Entreprenorskompetens i Lund AB, IES Interactive Executive Search AB, Gantus Training AB. Hans is also holder of Prosperus and auditor in Personalkooperativet Byns Forskola Ekonomisk forening. Previously, he held senior positions at E-vard MinDoktor.se Sverige AB, Jolife AB, Quick-Cool AB and Vivoline Medical AB. He was also Auditor at Bostadsrattsforeningen Langgardsgatan 17 and Solbacka Trading.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --